Children’s Hospital Colorado will participate in child vaccine study
COLORADO SPRINGS, Colo. (KKTV) - Children’s Hospital Colorado is participating in the Pfizer/BioNTech COVID-19 vaccine study for children ages 5 to 11.
The study will aim to see if the vaccine approved for those 12 and older, can produce an immune response, safely, in younger children.
Pediatric infectious disease expert and professor of pediatrics at the University of Colorado School of Medicine, Eric Simões, will lead the study.
Simões says, “Children need a vaccine,” as there are no approved COVID-19 vaccines available for children under the age of 12.
Children’s Colorado has already recruited and enrolled healthy children between the ages of 5 and 11.
The study will work like this:
“Each child is randomly assigned to receive either the study vaccine or a placebo in a 2:1 vaccine to placebo ratio. They will receive two injections approximately three weeks apart. Then, over the course of two years, families will have scheduled follow up study visits and be required to track any changes in their child’s health in an electronic diary.”
Neither the family or their doctor will know whether the child received the vaccine or the placebo until their follow up after six months.
Simões says with variants’ history in other countries, he is glad to help be proactive against that happening here.
“Why wait for it to happen before we try to prevent it?” he said. “Don’t wait for the hurricane to come before you put shutters in the window. Do it before. This is why I am really motivated to try and prevent the disease in children, because children are going to get infected.”
If you would like to learn more about the study, a full synopsis can be found HERE.
Copyright 2021 KKTV. All rights reserved.